Juan C. Ramirez
San Sebastian, PV 20014, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors.
Journal: Biomedicines
Published: September 12, 2024
Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing.
Journal: Viruses
Published: June 26, 2024
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment.
Journal: Molecular therapy. Methods & clinical development
Published: October 28, 2020
In Vitro and In Vivo Genetic Disease Modeling via NHEJ-Precise Deletions Using CRISPR-Cas9.
Journal: Molecular therapy. Methods & clinical development
Published: June 09, 2020
Radiation-Induced Malignant Transformation of Preneoplastic and Normal Breast Primary Epithelial Cells.
Journal: Molecular cancer research : MCR
Published: September 04, 2018
Gene Editing and CRISPR Therapeutics: Strategies Taught by Cell and Gene Therapy.
Journal: Progress in molecular biology and translational science
Published: November 19, 2017
Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9.
Journal: Stem cell reports
Published: August 30, 2016
Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system.
Journal: Nature communications
Published: February 14, 2014
An integration-defective lentivirus-based resource for site-specific targeting of an edited safe-harbour locus in the human genome.
Journal: Gene therapy
Published: July 12, 2013
Last Updated: 09/26/2026